Irene Blat

Head of External Innovation, North America, Servier

Irene Blat is the Head of External Innovation North America at Servier Pharmaceuticals. In her role, she identifies and cultivates early scientific opportunities across oncology, neurology, A.I. and pharmaceutical technology to align with long-term R&D priorities. Prior to her role at Servier, Irene was the Director of Business Development at Veracyte where she shaped and developed global business strategies to pursue both short and long-term revenue growth. Before this she held roles with increasing responsibility at Genuity Science where she was responsible for leading product strategy. Irene possesses a PhD in Oncology and Cancer Biology from MIT and a BS in Biology with a concentration in Pharmacology from Duke University.

Miriam Lopez Ramos

Head of Data and AI Products for Research, Servier

Miriam López Ramos is the Head of Data and AI Products for Research at Servier. In this role she is deeply involved in shaping the company’s strategy for AI. She oversees the implementation and deployment of data and AI tools to accelerate research. Prior to her current role she worked as a modeler at both Syngenta in Switzerland and AB Science in Paris before moving to the Paris-based biotech company Galapagos. At Galapagos, she progressively evolved from providing modeling support for drug discovery projects to managerial roles. She obtained her engineering degree from École Polytechnique in France and completed her PhD in organic chemistry and molecular modeling at Institut Curie.

Christopher Thurieau, PhD

Senior Executive Director and Global Head of Research, Servier

Christopher Thurieau, a healthcare executive with more than 35 years of experience in the field, is currently Executive Director of Research at Servier, where he manages the research centers in France, Denmark, Hungary and the USA. Before joining Servier in April 2017, Christophe Thurieau worked at Ipsen from 1996 to 2017. After holding various positions of increasing responsibility in Research and Development at Ipsen, in 2009 he became President of Ipsen Innovation and Senior Vice President of Global Scientific Affairs. He is the author of more than 30 original research articles published in international scientific journals and holds 25 patents. 

Stefan Gross

Senior Director and Head of Biochemistry, Servier

Olga Kolman, MD

Head of US Emerging Portfolio Strategy, Servier

Ankur Thacker

Director Alliance Management and Business Development, Servier